Global EditionASIA 中文双语Français
China
Home / China / Health

TCM product approved for sale in Singapore

By Zhang Yu in Shijiazhuang | chinadaily.com.cn | Updated: 2020-05-07 15:56
Share
Share - WeChat
A staff member works on the production line making Lianhua Qingwen capsules at Shijiazhuang Yiling Pharmaceutical Co in Shijiazhuang, Hebei province. [Photo provided to chinadaily.com.cn]

Applications for registration in more countries are underway, including countries in the Middle East, Africa and Latin America, the company said.

Lianhua Qingwen was recommended in four versions of a treatment plan from the National Health Commission for treating COVID-19, the pneumonia associated with the novel coronavirus.

On April 12, the National Medical Products Administration approved adding mild symptoms of COVID-19 as indications for which Lianhua Qingwen is effective.

|<< Previous 1 2 3 4 5 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US